Semaglutide Dosing Errors: FDA Warnings and How to Measure Correctly
Understanding the FDA's concerns about dosing confusion and how to accurately measure every injection.
FDA Safety Alert
The FDA has received reports of dosing errors with compounded semaglutide products, some resulting in hospitalizations. The primary issue is confusion between milligrams (the dose) and units (the volume marking on syringes). This article explains how to measure correctly and avoid these errors.
The surge in popularity of semaglutide for weight loss has brought with it a concerning wave of dosing errors, particularly with compounded formulations. The FDA has issued multiple communications warning healthcare providers and patients about the risk of medication errors when drawing semaglutide from multi-dose vials. Understanding the math behind dosing is critical for your safety.
What the FDA Is Worried About
The FDA's concerns center on several interconnected issues with compounded semaglutide:
1. Concentration Variability
Unlike brand-name Ozempic and Wegovy, which come in pre-filled pens with fixed concentrations, compounded semaglutide vials come in many different concentrations. One pharmacy may compound at 1 mg/mL, another at 2.5 mg/mL, and another at 5 mg/mL. A patient switching pharmacies or refilling from a different source may not realize the concentration changed, leading to a 2-5x dosing error.
2. Unit vs. Milligram Confusion
Insulin syringes are marked in "units," where 100 units = 1 mL. Semaglutide is prescribed in milligrams. The conversion between units (volume) and milligrams (drug amount) depends entirely on the concentration of the solution. This two-step calculation confuses many patients and even some healthcare providers.
3. Syringe Reading Errors
Insulin syringes come in different sizes (0.3 mL, 0.5 mL, 1 mL) with different marking increments. Reading small volumes on these syringes requires careful attention. A patient who misreads 5 units as 50 units would receive 10 times the intended dose.
4. Prescribing Inconsistencies
Some prescriptions specify the dose in milligrams, others in units, and others in milliliters. When the prescription format does not match the syringe markings, patients must perform conversions that introduce error opportunities.
Understanding Concentration: The Key to Correct Dosing
The concentration of your semaglutide vial is the single most important number to know. It tells you how much active semaglutide is in each milliliter of solution.
Common Compounded Semaglutide Concentrations
| Concentration | Volume for 0.25 mg | Volume for 0.5 mg | Volume for 1.0 mg | Volume for 2.5 mg |
|---|---|---|---|---|
| 1 mg/mL | 0.25 mL (25 units) | 0.50 mL (50 units) | 1.00 mL (100 units) | 2.50 mL (N/A*) |
| 2.5 mg/mL | 0.10 mL (10 units) | 0.20 mL (20 units) | 0.40 mL (40 units) | 1.00 mL (100 units) |
| 5 mg/mL | 0.05 mL (5 units) | 0.10 mL (10 units) | 0.20 mL (20 units) | 0.50 mL (50 units) |
| 10 mg/mL | 0.025 mL (2.5 units) | 0.05 mL (5 units) | 0.10 mL (10 units) | 0.25 mL (25 units) |
*Exceeds standard 1 mL syringe capacity. Not a practical volume for a single injection.
The Dose Calculation Formula
How to Calculate Your Injection Volume
Volume (mL) = Prescribed Dose (mg) / Concentration (mg/mL)
Example:
Prescribed dose: 0.5 mg | Vial concentration: 2.5 mg/mL
0.5 mg / 2.5 mg/mL = 0.20 mL = 20 units on an insulin syringe
Converting mL to Units:
On a standard 100-unit insulin syringe: 1 mL = 100 units
So multiply your mL result by 100 to get units
0.20 mL x 100 = 20 units
Step-by-Step: Measuring Your Dose Safely
- Verify your vial concentration. Read the label carefully. Find the mg/mL value. If you are unsure, call your pharmacy before injecting.
- Confirm your prescribed dose. Check your prescription or provider's instructions. Know the exact milligram amount you should be taking.
- Do the math. Divide your dose by the concentration to get the volume in mL. Multiply by 100 to convert to units if using an insulin syringe.
- Double-check. Many pharmacies include a dosing chart or instruction card with the vial. Compare your calculation to their chart.
- Use the right syringe. For small volumes (under 0.3 mL), use a 0.3 mL (30-unit) insulin syringe for better precision. For larger volumes, use a 0.5 mL or 1.0 mL syringe.
- Draw carefully. Hold the syringe at eye level. Align the top of the plunger (the flat edge closest to the needle) with the correct marking.
- Verify before injecting. Confirm the volume in the syringe matches your calculation before proceeding with the injection.
Real-World Dosing Errors Reported to the FDA
Reported Error Patterns:
- 5x overdose: Patient switched from 1 mg/mL to 5 mg/mL concentration without adjusting volume. Drew the same number of units, receiving 5 times the intended dose.
- 10x overdose: Patient confused "units" on the syringe with "milligrams" of semaglutide. Drew 50 units thinking it was 0.5 mg, but at 5 mg/mL, it was actually 2.5 mg.
- Wrong syringe: Patient used a tuberculin syringe marked in mL instead of an insulin syringe marked in units, leading to volume confusion.
- Misread markings: Patient with a 0.3 mL syringe misread the small hash marks and drew 0.25 mL instead of 0.025 mL, a 10x error.
Safety Tips to Prevent Dosing Errors
Dosing Safety Checklist
- Write it down. Keep a card next to your vial with your prescribed dose, concentration, and calculated volume. Review it before every injection.
- Ask for a dosing chart. Request that your pharmacy provide a specific dosing chart for your concentration when you fill your prescription.
- Verify new vials. Every time you open a new vial, verify the concentration on the label matches what you expect. If it changed, recalculate your volume.
- Use consistent syringe sizes. Stick with one syringe type and size so you become familiar with its markings.
- Good lighting. Draw your dose in a well-lit area where you can clearly see the syringe markings.
- Reading glasses if needed. Syringe markings are small. Use magnification if you have any difficulty reading them.
- Have someone check. Especially for the first few injections, have a family member or partner verify your syringe volume against your calculated dose.
Why Pre-Filled Pens Eliminate These Risks
Brand-name semaglutide pens (Ozempic, Wegovy) virtually eliminate dosing errors because:
- The dose selector clicks to preset mg amounts
- No concentration math is required
- No syringe reading is needed
- The pen delivers a fixed volume for each dose setting
- Dose confirmation windows show the selected dose
The trade-off is cost. Compounded semaglutide is significantly less expensive, but requires patient education about proper dosing technique. If the math and measuring create anxiety, discuss this with your provider. The confidence that comes from an accurate dose is important for treatment adherence.
What Your Provider Should Do
Good prescribers of compounded semaglutide should:
- Specify the dose in milligrams AND the volume in mL or units on the prescription
- Include the concentration in their instructions
- Provide a dosing chart or calculator specific to your concentration
- Demonstrate proper syringe technique or provide instructional videos
- Follow up early in treatment to verify you are measuring correctly
- Ask about dosing confidence at each check-in
Key Takeaways
- Dosing errors with compounded semaglutide are a documented FDA concern
- The main risk is confusing units (volume) with milligrams (drug amount)
- Always know your vial's concentration before calculating your dose
- Use the formula: Volume = Dose / Concentration
- Keep a written dosing reference next to your medication
- Verify the concentration on every new vial
- When in doubt, call your pharmacy before injecting
Medical Disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice. Always follow your prescriber's specific dosing instructions. If you are unsure about your dose calculation, contact your pharmacy or healthcare provider before injecting.
Clear Dosing Instructions with Every Prescription
Trimi Health provides personalized dosing charts, video instructions, and medical team access with every prescription.
Get Started TodayMore on common mistakes
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).